Henrik Franzyk
Associate Professor
henrik.franzyk@sund.ku.dk
Cancer and Infectious Diseases
Through truly interdisciplinary collaborations, the cluster aims at discovery and optimization of MDR anticancer and/or antimicrobial lead compounds and validate these by in vitro and in vivo models.
The risk of resistance development will be estimated and investigated through mechanistic studies-
Cluster leader
Core members
Associate professor Peptide-based Drug Research Group |
Professor Björkling Group |
Associate professor Molecular Disease Biology Group |
Professor Specialised Metabolites Group |
Assistant professor Bioanalytical Chemistry and Metabolomics Group |
Associate professor Drug Transporters Group |
Associate professor Peptide-based Drug Research Group |
Professor Bioanalytical Chemistry and Metabolomics Group |
Associated members
• José Moreira, Professor MSO, Molecular & Cellular Pharmacology
• Matthias Herth, Associate professor, Herth Group
• Lennart Bunch, Associate professor, Bunch Research Group
• Dan Stærk, Professor, Bioanalytical Chemistry and Metabolomics Group
• Jens Soelberg, Senior curator, Peptides & Proteins